Jessica J. Kandel to Angiogenesis Inhibitors
This is a "connection" page, showing publications Jessica J. Kandel has written about Angiogenesis Inhibitors.
Connection Strength
1.079
-
Antiangiogenic therapy for the treatment of pediatric solid malignancies. Semin Pediatr Surg. 2004 Feb; 13(1):53-60.
Score: 0.191
-
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
Score: 0.164
-
Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg. 2001 Feb; 36(2):357-61.
Score: 0.155
-
Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound Med Biol. 2012 Jun; 38(6):1019-29.
Score: 0.084
-
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
Score: 0.063
-
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist Updat. 2004 Aug-Oct; 7(4-5):289-300.
Score: 0.049
-
TNP-470 promotes initial vascular sprouting in xenograft tumors. Mol Cancer Ther. 2004 Mar; 3(3):335-43.
Score: 0.048
-
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma. Int J Oncol. 2003 Dec; 23(6):1651-5.
Score: 0.047
-
VEGF blocking therapy in the treatment of cancer. Expert Opin Biol Ther. 2003 Apr; 3(2):263-76.
Score: 0.045
-
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg. 2003 Mar; 38(3):308-14; discussion 308-14.
Score: 0.045
-
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proc Natl Acad Sci U S A. 2002 Aug 20; 99(17):11399-404.
Score: 0.043
-
Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg. 2002 Jun; 37(6):857-61.
Score: 0.043
-
Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J Pediatr Surg. 2002 Mar; 37(3):518-22.
Score: 0.042
-
All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. J Pediatr Surg. 2001 Feb; 36(2):287-90.
Score: 0.039
-
Monitoring early tumor response to drug therapy with diffuse optical tomography. J Biomed Opt. 2012 Jan; 17(1):016014.
Score: 0.021